Author:
Partridge Ann H.,Wolff A. C.,Marcom P. K.,Kaufman P. A.,Zhang L.,Gelman R.,Moore C.,Lake D.,Fleming G. F.,Rugo H. S.,Atkins J.,Sampson E.,Collyar D.,Winer E. P.
Publisher
Springer Science and Business Media LLC
Reference28 articles.
1. Jemal A, Siegel R, Ward E et al (2007) Cancer statistics, 2007. CA Cancer J Clin 57:43–66
2. Wittes RE, Friedman MA (1988) Accrual to clinical trials. J Natl Cancer Inst 80:884–885. doi: 10.1093/jnci/80.12.884
3. Comis RL, Aldige CR, Stovall EL et al (2000) A quantitative survey of public attitudes towards cancer clinical trials—a Harris Interactive poll. pp 1–10. www.cancersummit.org
4. Cancer Leadership Counsel Cancer Research Foundation of America, Coalition of National Cancer Cooperative Groups et al. (2000) The summit series on clinical trials website—recommendations and action steps. www.cancersummit.org
5. Partridge AH, Winer EP (2002) Informing clinical trial participants about study results. JAMA 288:363–365. doi: 10.1001/jama.288.3.363